Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

PCOS is a hormonal disorder in women that can cause infertility and increases the risk of heart and metabolic issues.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Manipulating cell cleanup processes could help treat hair loss.

A patient with Werner syndrome showed a range of aging-like symptoms and metabolic issues, underscoring the need for early detection and treatment.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Hair loss in women linked to higher sexual dysfunction risk.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

The document discusses new insights into how hormones affect male sexual health and related conditions.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Being overweight, having gallbladder removal surgery, and taking cholesterol-lowering drugs are linked to a higher chance of getting vulvar lichen sclerosus.

Resveratrol improved menstrual regularity and reduced hair loss in women with PCOS.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

A woman experienced vertigo and hearing loss after weight loss surgery, possibly due to eustachian tube issues from fat loss around ear muscles.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Biotin treatment can significantly improve hair loss and motor functions in certain metabolic disorders.

Obesity harms skin health by causing inflammation and delayed wound healing.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Finasteride for hair loss can cause erectile dysfunction due to tissue fibrosis.

Ferulic acid may help control menstrual cycle-related epilepsy by affecting female hormones.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.